Flores, Analyn .

HRN: 04-88-81  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2023
CEFUROXIME 500MG (TAB)
10/23/2023
10/29/2023
ORAL
500mg
BID
Sp Cs
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: